1408087-20-6

Basic information

• Product Name: 2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-(3-fluorophenyl)-5-morpholino-4H-chromen-4-one
• Synonyms: 2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-(3-fluorophenyl)-5-morpholino-4H-chromen-4-one
• CAS NO: 1408087-20-6
• Molecular Weight: 638.674
• Mol File: 1408087-20-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-(3-fluorophenyl)-5-morpholino-4H-chromen-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-(3-fluorophenyl)-5-morpholino-4H-chromen-4-one(1408087-20-6)
• EPA Substance Registry System: 2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-3-(3-fluorophenyl)-5-morpholino-4H-chromen-4-one(1408087-20-6)

Safety Data

• Hazardous Substances Data: 1408087-20-6(Hazardous Substances Data)

Upstream product

• 1408087-64-8 3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1408087-79-5 2-(1-bromoethyl)-5-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one 
• 1408087-78-4 2-ethyl-5-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one 
• 1408087-76-2 3-bromo-2-ethyl-5-fluoro-4H-chromen-4-one 
• 1408087-74-0 2-ethyl-5-fluoro-4H-chromen-4-one 
• 1408087-72-8 2-acetyl-3-fluorophenyl propionate 
• 1350426-06-0 2-(3-fluoro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 120484-49-3 1-(2-fluoro-6-methoxyphenyl)ethan-1-ol 
• 456-49-5 1-fluoro-3-methoxybenzene 
• 202865-80-3 4-bromo-2-fluoro-1-isopropoxybenzene 
• 146137-74-8 2-fluoro-6-methoxybenzaldehyde 
• 2105-94-4 4-bromo-2-fluorophenol 
• 93339-98-1 1-(2-fluoro-6-hydroxyphenyl)ethan-1-one 
• 120484-50-6 1-(2-Fluoro-6-methoxyphenyl)ethanone 

Relevant articles and documents

NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.